Cymbalta: FDA panel gives a qualified nod to antidepressant for chronic pain - latimes.com
Links shared publicly online about this topic.
- 931total visits
Cymbalta: FDA panel gives a qualified nod to antidepressant for chronic pain - latimes.com
A government advisory panel says the FDA should allow marketing of the antidepressant Cymbalta for a wider range of pain, including chronic back pain.
View full resource at latimes.com
Tags: Pain, Back Pain, Chronic Pain, Anxiety Medication, Antidepressant, Fibromyalgia Medication, FDA, Cymbalta
Most Recently Shared on August 21, 2010 at 6:49 pm By:
FDA panel gives a qualified nod to antidepressant for chronic pain - http://bit.ly/ca8sQ7 << to "include those with chronic back pain"
Advertisement
